ArticleBreast cancer (Dove Medical Press)2019

Primary systemic therapy in HER2-positive operable breast cancer using trastuzumab and chemotherapy: efficacy data, cardiotoxicity and long-term follow-up in 142 patients diagnosed from 2005 to 2016 at a single institution.

Silvia Antolín et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.